Black Diamond Therapeutics (BDTX) Net Margin (2025)
Black Diamond Therapeutics' Net Margin history spans 1 years, with the latest figure at 78.75% for Q1 2025.
- For Q1 2025, Net Margin changed N/A year-over-year to 78.75%; the TTM value through Dec 2025 reached 23.69%, changed N/A, while the annual FY2025 figure was 23.69%, N/A changed from the prior year.
- Net Margin reached 78.75% in Q1 2025 per BDTX's latest filing.
- In the past five years, Net Margin ranged from a high of 78.75% in Q1 2025 to a low of 78.75% in Q1 2025.